指南与共识心外重症与机械循环支持

心力衰竭相关心源性休克:ISHLT共识会议内容摘要

Heart failure related cardiogenic shock: An ISHLT consensus conference content summary.
指南 / 共识 · J Heart Lung Transplant · 2023-12-08

国际心肺移植学会(ISHLT)组织54名来自全球42个中心的专家召开共识会议,旨在更好地定义、诊断和管理心力衰竭相关心源性休克(HF-CS)。本文总结会议前半部分对HF-CS的当代文献综述,指出尽管药物和器械治疗有进步,HF-CS短期死亡率仍高达50%,且缺乏高质量证据支持标准化临床实践。

要点

  • HF-CS占所有心源性休克病例的>50%,但短期死亡率仍高达50%。
  • HF-CS领域缺乏高质量证据支持标准化临床实践。
  • ISHLT共识会议旨在统一HF-CS定义、诊断与管理策略。

核心结论

  • 尽管药物和器械治疗有所改善,心源性休克短期死亡率仍高达50%。
  • HF-CS占心源性休克病例的>50%,但研究多集中于急性心肌梗死相关心源性休克。
  • HF-CS领域缺乏高质量证据支持标准化临床实践,且入院时疾病特异性诊断和风险分层策略存在未满足需求。

研究设计与样本

  • ISHLT组织共识会议,54名参与者来自全球42个中心,包括晚期心衰和介入心脏病专家、心胸外科医生、重症监护心脏病专家、重症监护医师、药师和 allied health professionals。
  • 会议包括HF-CS最新进展报告及后续分组讨论,旨在就CS照护模式、HF-CS患者表现和管理策略等问题达成共识。
  • 本文总结会议前半部分对HF-CS的当代文献综述(第1部分),伴随文件(第2部分)涵盖分组讨论内容。

主要发现

  • HF-CS占所有心源性休克病例的>50%。
  • 心源性休克短期死亡率仍高达50%。
  • 心源性休克的定义、患者表型、治疗目标和疗法的异质性导致难以比较已发表报告和标准化治疗算法。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In recent years, there have been significant advancements in the understanding, risk-stratification, and treatment of cardiogenic shock (CS). Despite improved pharmacologic and device-based therapies for CS, short-term mortality remains as high as 50%. Most recent efforts in research have focused on CS related to acute myocardial infarction, even though heart failure related CS (HF-CS) accounts for >50% of CS cases. There is a paucity of high-quality evidence to support standardized clinical practices in approach to HF-CS. In addition, there is an unmet need to identify disease-specific diagnostic and risk-stratification strategies upon admission, which might ultimately guide the choice of therapies, and thereby improve outcomes and optimize resource allocation. The heterogeneity in defining CS, patient phenotypes, treatment goals and therapies has resulted in difficulty comparing published reports and standardized treatment algorithms. An International Society for Heart and Lung Transplantation (ISHLT) consensus conference was organized to better define, diagnose, and manage HF-CS. There were 54 participants (advanced heart failure and interventional cardiologists, cardiothoracic surgeons, critical care cardiologists, intensivists, pharmacists, and allied health professionals), with vast clinical and published experience in CS, representing 42 centers worldwide. State-of-the-art HF-CS presentations occurred with subsequent breakout sessions planned in an attempt to reach consensus on various issues, including but not limited to models of CS care delivery, patient presentations in HF-CS, and strategies in HF-CS management. This consensus report summarizes the contemporary literature review on HF-CS presented in the first half of the conference (part 1), while the accompanying document (part 2) covers the breakout sessions where the previously agreed upon clinical issues were discussed with an aim to get to a consensus.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Kanwar MK, Billia F, Randhawa V, et al. Heart failure related cardiogenic shock: An ISHLT consensus conference content summary. J Heart Lung Transplant. 2023. PMID: 38069920. doi:10.1016/j.healun.2023.09.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。